drugset / Trial / NCT03424733

Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects

NCT03424733

Phase 4 Unknown 50 enrolled Holy Name Medical Center, Inc. Biogen · collab
Non-randomizedCrossoverOpen-labelPrevention

Summary

Some of the most common side effects of the multiple sclerosis drug Plegridy (pegylated interferon beta-1a) include flu-like symptoms and injection site reactions. Physicians often advise patients to take Tylenol or aspirin prior to injection, but in this study the investigators evaluated whether using a low dose of oral steroid in combination with Tylenol reduced flu-like symptoms and injection site reactions.

Timeline

Start
2017-09-25
Primary completion
2020-05-01
Completion
2020-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 650 mg Oral
Subject Prednisone Other / unclassified 20 mg Oral
Background peginterferon beta-1a Protein / enzyme biologic 125 ug Subcutaneous

Indications